Results 211 to 220 of about 162,472 (321)

Vascular smooth muscle constrictive activity of endothelin-related peptides.

open access: gold, 1989
Tomoko Kashiwabara   +6 more
openalex   +1 more source

Absence of Functional Autoantibodies Targeting Angiotensin II Receptor Type 1 and Endothelin‐1 Type A Receptor in Circulation and Purified IgG From Patients With Systemic Sclerosis

open access: yesArthritis &Rheumatology, Volume 77, Issue 7, Page 901-913, July 2025.
Objective Systemic sclerosis (SSc) is a rare but severe autoimmune disease characterized by immune dysregulation, fibrosis, and vasculopathy. Although previous studies have highlighted the presence of functional autoantibodies targeting the angiotensin II receptor type 1 (AT1) and endothelin‐1 type A receptor (ETAR), leading to autoantibody‐mediated ...
Wieke M. van Oostveen   +8 more
wiley   +1 more source

Altered Endothelin Receptor Expression in Idiopathic Male Infertility: A Potential Therapeutic Target. [PDF]

open access: yesUrol Res Pract
Weiten R   +6 more
europepmc   +1 more source

Endothelin increased renal secretion of prostaglandin (PG) E2 and 6-keto-PGF1α

open access: gold, 1989
Tokihito Yukimura   +8 more
openalex   +1 more source

Messenger RNA expression and synthesis of endothelin-1 along rat nephron segments. [PDF]

open access: bronze, 1992
Kazutomo Ujiie   +5 more
openalex   +1 more source

Serum Type I Interferon Score for Prediction of Clinically Meaningful Disease Progression in Limited Cutaneous Systemic Sclerosis

open access: yesArthritis &Rheumatology, Volume 77, Issue 7, Page 929-941, July 2025.
Objective To assess the value of serum type I interferon (IFN) score in predicting clinically meaningful progression in limited cutaneous systemic sclerosis (lcSSc) using a novel composite endpoint adopted from the MINIMISE clinical trial. Methods A retrospective, longitudinal lcSSc cohort was identified within a national, multicenter observational ...
Stefano Di Donato   +9 more
wiley   +1 more source

Attenuation of ischemic liver injury by a non-selective endothelin receptor antagonist [PDF]

open access: yes, 1997
Ishizaki, N   +8 more
core   +1 more source

Hyperhomocysteinemia‐Driven Ischemic Stroke: Unraveling Molecular Mechanisms and Therapeutic Horizons

open access: yesFood Science &Nutrition, Volume 13, Issue 7, July 2025.
Neurotoxicity of Hcy. (A figure that best represents the scope of the paper.) Homocysteine can reduce the tightness of endothelial cell connections, increase vascular permeability, and damage the blood–brain barrier. Homocysteine activates various glutamate receptors on the surfaces of neurons and glial cells, triggering excitotoxicity, promoting the ...
Bin Li, Yushun Kou, Lingna Zhang, Lin Yi
wiley   +1 more source

Influence of Atherosclerosis-Associated Risk Factors on Expression of Endothelin Receptors in Advanced Atherosclerosis. [PDF]

open access: yesInt J Mol Sci
Herbers O   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy